Understanding the Advantages & Disadvantages of Using Real World Data for the Assessment of Adherence & Persistence with Obesity Medications to Predict Payer Pushback
Time: 9:30 am
day: Conference Day Two
Details:
- Discussing the best sources of RWE and HEOR to improve validity and reliability of studies
- Exploring the advantages of large sample sizes, longitudinal patient journeys and diverse population to gain the most accurate understanding of patient adherence and persistence with obesity medications outside of controlled clinical trial settings
- Uncover the limitations and potential biases associated with real-world data and the difficulty in isolating situational variabilities in real-world settings
